Indian Therapeutic Monoclonal Antibodies Market to Grow at a CAGR of 27% during 2011-2016
The study, that has been undertaken using desk-based as well as qualitative primary market research provides and draws upon a comprehensive analysis of the Indian therapeutic monoclonal antibodies market.
IMARC Group, one of the world’s leading research and advisory firms, in its latest study “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” finds that driven by factors such as a large patient pool, strong biomanufacturing capabilities, absence of an Indian patent for most
↧